EMOTION: Cognition and Emotion in the SII and IBD
Study Details
Study Description
Brief Summary
The study aims at showing that the susceptibility in the stress is more raised at the person affected digestive pathologies (SII or IBD) in forgiveness than healthy subjects.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The objective of the study which we wish to lead consists in looking for, at the patients SII and IBD in forgiveness, the existence of a correlation between the rate of cortisol(Hormone of the stress) and the level of HRV (Heart Rate Variability) to estimate the inhibitive fronto-amygdalien tonus.
So we make the hypothesis that the persons affected by digestive pathologies of type SII or IBD would present an emotional and physiological vulnerability more important than unhurt subjects of pathologies.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Control group 30 Asymptomatic Healthy Volunteers Intervention : Observation of emotional behavior in asymptomatic healthy volunteers subjected to stress. |
Behavioral: emotion
Show that the susceptibility in the stress (recording of Heart Rate Variability;viewing films;...) is more important at the person affected by digestive pathologies (SII or IBD) in forgiveness than to unhurt subjects of pathologies.
Other Names:
|
Experimental: Experimental group Persons reached by digestive pathologies (SII or IBD). Group SII : 30 patients Group IBD: 60 patients (30 patients RCH and 30 patients CD) Intervention : Observation of emotional behavior in person affected by digestive pathologies subjected to stress. |
Behavioral: emotion
Show that the susceptibility in the stress (recording of Heart Rate Variability;viewing films;...) is more important at the person affected by digestive pathologies (SII or IBD) in forgiveness than to unhurt subjects of pathologies.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- RATE PLASMATIQUE OF CORTISOL COUPLED WITH THE CARDIAC VARIABILITY [24 MONTHS]
Secondary Outcome Measures
- SCORES OF DEPRESSIVE SYMPTOMATOLOGIE AND ANXIETY, RATE PLASMATIQUES OF CATECHOLAMINES, LEPTINE, ADIPONECTINE AND PRO-INFLAMMATORY CYTOKINES. [24 MONTHS]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with SII :Membership to the Social Security,SII defined according to the criteria Rome III.
-
Patients with IBD :Membership to the Social Security,patients with a ulcerative colitis(UC) or a Crohn's disease (CD)ileal and/or colic.
Exclusion Criteria:
-
Existence of a severe affectation on the general plan (cardiac,respiratory,hematological,renal,hepatic,cancerous),
-
Subject diabetic,
-
Pregnant or breast-feeding woman,
-
Subject included in another clinical and\or therapeutic trial or having been included in a clinical and\or therapeutic trial for less than a month,
-
Subject presenting a psychiatric pathology evident,
-
Person under guardianship.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hôpital Michallon-CHU Grenoble | Grenoble | France | 38000 |
Sponsors and Collaborators
- University Hospital, Grenoble
- French National Society of Gastroenterology
- Association François Aupetit
Investigators
- Principal Investigator: Bruno Bonaz, MD-PhD,
Study Documents (Full-Text)
None provided.More Information
Publications
- Graff LA, Walker JR, Clara I, Lix L, Miller N, Rogala L, Rawsthorne P, Bernstein CN. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol. 2009 Dec;104(12):2959-69. doi: 10.1038/ajg.2009.529. Epub 2009 Sep 15.
- Pellissier S, Dantzer C, Canini F, Mathieu N, Bonaz B. Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome. Psychoneuroendocrinology. 2010 Jun;35(5):653-62. doi: 10.1016/j.psyneuen.2009.10.004. Epub 2009 Nov 11.
- Pellissier S, Dantzer C, Canini F, Mathieu N, Bonaz B. Toward a definition of a global psycho-physiological criterion of vulnerability to relapse in inflammatory bowel diseases. Am J Gastroenterol. 2010 Jun;105(6):1446-7. doi: 10.1038/ajg.2009.763.
- 0817
- 2008-A00994-51